David Kerr, MA, MD

Opinion

Are Targeted Drugs the Future in Colorectal Cancer?

Author:: David Kerr, MA, MD

Publish date: October 8, 2024

Preliminary results from three trials suggest some benefits of cetuximab plus irinotecan in patients who’d already had epidermal growth factor rece...